{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:57:56Z","timestamp":1792699076096,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>It is well known that atrial fibrillation (AF) carried a high risk of cognitive decline, which is independent of stroke or transient ischemic attack (TIA). Whether anticoagulation is associated with reduced risk of cognitive decline in participants with AF still remains controversial. We conducted a systematic review and meta-analysis to explore the effect of anticoagulation on the risk of cognitive decline in patients with AF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We systematically searched the PubMed, Embase and the Cochrane Database for eligible studies published up to January 2018. Risk ratios (RR) with 95% confidence interval (CI) for cognitive decline were extracted, and pooled estimations were calculated using the fixed effects model. Subgroup analyses were further performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eight relevant articles involved 454,273 patients were ultimately included in this meta-analysis. We found that anticoagulation was associated with reduced risk of cognitive impairment as compared with nonanticoagulation (RR 0.72, 95% CI 0.69\u20130.75, <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup> 11.5%). This reduction was still significant after adjustment for stroke and TIA (RR 0.72, 95% CI 0.69\u20130.74, <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup> 0.0%). In the subgroup analyses, the incidence of cognitive decline was significantly decreased in those treated with anticoagulation compared to no treatment (RR 0.72, 95% CI 0.69\u20130.75, <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup> 0.0%), but the cognitive benefit showed no significant difference between anticoagulant and antiplatelet treatment (RR 1.01, 95% CI 0.68\u20131.50, <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup> 46.8%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Anticoagulation is associated with cognitive benefit in participants with AF independent of stroke and TIA, but it was not superior to antiplatelet drugs in reducing the risk of cognitive decline.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014499","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T05:59:03Z","timestamp":1550123943000},"page":"e14499","source":"Crossref","is-referenced-by-count":27,"title":["Anticoagulation in atrial fibrillation and cognitive decline"],"prefix":"10.1097","volume":"98","author":[{"given":"Decai","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunLan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1212\/WNL.0b013e31820f2e38","article-title":"Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis","volume":"76","author":"Kwok","year":"2011","journal-title":"Neurology"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"j5058","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"Lopez-Lopez","year":"2017","journal-title":"BMJ"},{"key":"R5-20230914","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006443","article-title":"Longitudinal effect of stroke on cognition: a systematic review","volume":"7","author":"Tang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/STROKEAHA.114.005243","article-title":"Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study","volume":"45","author":"Chen","year":"2014","journal-title":"Stroke"},{"key":"R7-20230914","first-page":"863","article-title":"Warfarin therapy is associated with lower risk of dementia in patients with incident atrial fibrillation in a community based cohort","volume":"36","author":"Hu","year":"2015","journal-title":"Eur Heart J"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jalz.2013.05.1233","article-title":"Antithrombotic medication use and dementia incidence among people with mild cognitive impairment and atrial fibrillation","volume":"9","author":"Meranus","year":"2013","journal-title":"Alzheimer's Dement"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ageing\/afw104","article-title":"Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review","volume":"45","author":"Moffitt","year":"2016","journal-title":"Age Ageing"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","article-title":"Less dementia with oral anticoagulation in atrial fibrillation","volume":"39","author":"Friberg","year":"2018","journal-title":"Eur Heart J"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Internal Med"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"d2090","DOI":"10.1136\/bmj.d2090","article-title":"How to obtain the confidence interval from a P value","volume":"343","author":"Altman","year":"2011","journal-title":"BMJ"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1538-7836.2004.00993.x","article-title":"Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation","volume":"2","author":"Barber","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjopharm.2009.06.002","article-title":"Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and\/or early-stage dementia: a single-center, retrospective, observational study","volume":"7","author":"Jacobs","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"R17-20230914","first-page":"ii120","article-title":"Did warfarin and antiplatelet reduce the incidence of dementia in patients with atrial fibrillation: a nationwide cohort study","volume":"15","author":"Liao","year":"2013","journal-title":"Europace"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/STROKEAHA.113.004009","article-title":"Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)","volume":"45","author":"Mavaddat","year":"2014","journal-title":"Stroke"},{"key":"R19-20230914","first-page":"S598","article-title":"Lower time in therapeutic range on warfarin correlates with incident dementia in patients with atrial fibrillation","volume":"13","author":"Hu","year":"2016","journal-title":"Heart Rhythm"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.archger.2017.05.014","article-title":"Dementia correlates with anticoagulation underuse in older patients with atrial fibrillation","volume":"72","author":"Viscogliosi","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mayocp.2017.09.021","article-title":"Efficacy of warfarin anticoagulation and incident dementia in a community-based cohort of atrial fibrillation","volume":"93","author":"Madhavan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"R22-20230914","first-page":"1080","article-title":"Inadequacy of oral anticoagulation is a crucial factor for development of dementia in patients with permanent atrial fibrillation","volume":"36","author":"Petroni","year":"2015","journal-title":"Eur Heart J"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jamda.2011.04.005","article-title":"High rate of anticoagulation therapy in oldest old subjects with atrial fibrillation: the octabaix study","volume":"13","author":"Formiga","year":"2012","journal-title":"J Am Med Directors Assoc"},{"key":"R24-20230914","first-page":"iv44","article-title":"Antithrombotic strategies and new-onset dementia in patients with atrial fibrillation","volume":"19","author":"Wong","year":"2017","journal-title":"Europace"},{"issue":"(5 Pt 1)","key":"R25-20230914","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-158-5-201303050-00007","article-title":"Cognitive impairment associated with atrial fibrillation: a meta-analysis","volume":"158","author":"Kalantarian","year":"2013","journal-title":"Ann Intern Med"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.2015.6968","article-title":"Trajectory of cognitive decline after incident stroke","volume":"314","author":"Levine","year":"2015","journal-title":"JAMA"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","article-title":"Post-stroke dementia: a comprehensive review","volume":"15","author":"Mijajlovic","year":"2017","journal-title":"BMC Med"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/eurheartj\/ehx208","article-title":"Atrial fibrillation as a risk factor for cognitive decline and dementia","volume":"38","author":"Singh-Manoux","year":"2017","journal-title":"Eur Heart J"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cjca.2010.11.007","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter","volume":"27","author":"Cairns","year":"2011","journal-title":"Canad J Cardiol"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1253\/circj.CJ-88-0001","article-title":"Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version","volume":"74","year":"2010","journal-title":"Circ J"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(02)00256-3","article-title":"Similarities between Alzheimer's disease and vascular dementia","volume":"203\u2013204","author":"Kalaria","year":"2002","journal-title":"J Neurol Sci"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/eurheartj\/ehx320","article-title":"Does atrial fibrillation lead to cognitive decline and dementia?","volume":"38","author":"Diener","year":"2017","journal-title":"Eur Heart J"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/eurheartj\/ehn341","article-title":"Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy","volume":"29","author":"Knecht","year":"2008","journal-title":"Eur Heart J"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2017.05.102","article-title":"Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation","volume":"243","author":"Bellmann","year":"2017","journal-title":"Int J Cardiol"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2013.05.074","article-title":"Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function","volume":"62","author":"Gaita","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.005","article-title":"Cerebral microbleeds and asymptomatic cerebral infarctions in patients with atrial fibrillation","volume":"23","author":"Saito","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/ene.12608","article-title":"Prevalence of atrial fibrillation and association of previous antithrombotic treatment in patients with cerebral microbleeds","volume":"22","author":"Horstmann","year":"2015","journal-title":"Eur J Neurol"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.hrthm.2014.08.013","article-title":"Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia","volume":"11","author":"Jacobs","year":"2014","journal-title":"Heart Rhythm"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.jacc.2017.03.540","article-title":"Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation","volume":"69","author":"Marzec","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R41-20230914","first-page":"899","article-title":"Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark","volume":"38","author":"Gadsboll","year":"2017","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902150-00054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:25:50Z","timestamp":1694719550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902150-00054"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014499","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}